Zhejiang Medicine Co. Ltd Financials

Market Capitalization CN¥15.37 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	15.67
Forward PE	25.37
Price to Sales TTM	CN¥1.70
Price to Book MRQ	CN¥1.49
Enterprise to Revenue	3.37
Enterprise to EBITDA	22.18

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	10.83%
Operating Margin	26.63%
Return on Assets TTM	3.50%
Return on Equity TTM	8.33%

Income Statement

Revenue TTM	CN¥9,030,431,744
Revenue per Share TTM	CN¥9.45
Quarterly Revenue Growth	39.70%
Gross Profit TTM	CN¥2,524,267,281
EBITDA	CN¥905,530,011
Net Income to Common TTM	CN¥977,952,832
Diluted EPS TTM	CN¥1.02
Quarterly Earnings Growth YoY	1737.60%

Balance Sheet

Total Cash MRQ	CN¥1,963,916,288
Total Cash per Share MRQ	CN¥1.02
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	7.07
Current Ratio MRQ	2.61
Book Value per Share MRQ	CN¥10.75

Cash Flow

Operating Cash Flow TTM	CN¥915,668,160
Levered Free Cash Flow TTM	CN¥312,587,968

600216 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	961,638,016
Float Shares	1,163,639,376
Avg 10 Volume	14,854,034
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	47.32%
% Held by Institutions	5.52%

Stock Price Summary

Beta	0.10
Fifty Two Week Low	CN¥7.97
Fifty Two Week High	CN¥19.40
Fifty Two Week Change	34.70%
Day 50 MA	CN¥16.78
Day 200 MA	CN¥13.10

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.60
Forward Annual Dividend Yield	4.03%
Trailing Annual Dividend Rate	CN¥0.15
Trailing Annual Dividend Yield	1.01%
Payout Ratio	14.71%
Dividend Date
Ex Dividend Date	2024-07-10
Last Split Factor
Last Split Date	2013-10-09